TY - JOUR
AU - Lamb, Harriet
AB - CNS Drugs 2000 Jul; 14 (1): 51-80 ADIS DRUG EVALUATION 1172-7047/00/0007-0051/$20.00/0 © Adis International Limited. All rights reserved. A Review of its Use in Anxiety Disorders and Mixed Anxiety and Depression Miriam Hurst and Harriet M. Lamb Adis International Limited, Auckland, New Zealand Various sections of the manuscript reviewed by: G. Fava, Department of Psychology, University of Bologna, Bologna, Italy; C.G. Fichtner, Illinois Department of Human Services, Office of Mental Health, North Chicago, Illinois, USA; I. Hindmarch, HPRU Medical Research Centre, University of Surrey, Guildford, Surrey, England; J.J. López-Ibor, Hospital Universitario, San Carlos, Madrid, Spain; G. Maina, Department of Neuroscience, Psychiatric Unit, University of Turin, Turin, Italy; C. Prakash, Auckland, New Zealand; J. Tauscher, Centre for Addiction and Mental Health, Clarke Institute of Psychiatry, Toronto, Ontario, Canada; P.J. Tyrer, Paterson Centre, London, England; M. Van Ameringen, Anxiety Disorders Clinic, McMaster University Medical Centre, Hamilton, Ontario, Canada. Data Selection Sources: Medical literature published in any language since 1983 on fluoxetine, identified using AdisBase (a proprietary database of Adis International, Auckland, New Zealand) and Medline. Additional references were identified from the reference lists of published articles. Bibliographical information, including contributory unpublished data, was also requested from the company developing the drug. 
TI - Fluoxetine
JF - CNS Drugs
DO - 10.2165/00023210-200014010-00005
DA - 2012-09-14
UR - https://www.deepdyve.com/lp/springer-journals/fluoxetine-L60fciPkV0
SP - 51
EP - 80
VL - 14
IS - 1
DP - DeepDyve
ER -